$3.02 Billion is the total value of Perceptive Advisors's 132 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 58.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Sell | NEUROCRINE BIOSCIENCES | $399,712,000 | -31.9% | 5,151,589 | -46.2% | 13.25% | +18.2% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $257,417,000 | -52.3% | 17,888,597 | -50.0% | 8.53% | -17.2% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $192,384,000 | -27.3% | 4,889,066 | -42.7% | 6.38% | +26.1% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $169,079,000 | -59.8% | 1,330,802 | -62.8% | 5.60% | -30.2% |
| ZGNX | Sell | ZOGENIX INC | $160,799,000 | -37.5% | 3,970,357 | -45.9% | 5.33% | +8.5% |
| LJPC | Sell | LA JOLLA PHARMACEUTICAL CO | $109,046,000 | -27.3% | 3,388,611 | -21.5% | 3.62% | +26.2% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $86,000,000 | +45.3% | 1,140,434 | +34.3% | 2.85% | +152.3% |
| ANAB | Sell | ANAPTYSBIO INC | $76,183,000 | +11.0% | 756,387 | -61.5% | 2.52% | +92.6% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $69,573,000 | -68.6% | 703,820 | -61.9% | 2.31% | -45.4% |
| XLRN | Sell | ACCELERON PHARMA INC | $68,594,000 | -43.1% | 1,616,259 | -50.0% | 2.27% | -1.3% |
| RTRX | Sell | RETROPHIN INC | $56,310,000 | -57.9% | 2,672,525 | -50.3% | 1.87% | -26.9% |
| CORI | Sell | CORIUM INTL INC | $56,191,000 | -56.6% | 5,847,133 | -50.0% | 1.86% | -24.7% |
| AVXS | Sell | AVEXIS INC | $53,137,000 | -59.1% | 480,141 | -64.2% | 1.76% | -29.0% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $52,571,000 | +4.0% | 2,490,381 | -10.4% | 1.74% | +80.6% |
| DOVA | Sell | DOVA PHARMACEUTICALS INC | $52,099,000 | -38.8% | 1,809,015 | -48.4% | 1.73% | +6.2% |
| RGNX | Sell | REGENXBIO INC | $47,254,000 | -50.2% | 1,421,186 | -50.7% | 1.57% | -13.6% |
| VBIV | Sell | VBI VACCINES INC | $41,273,000 | -18.4% | 9,665,843 | -26.4% | 1.37% | +41.8% |
| ABMD | Buy | ABIOMED INC | $40,293,000 | +131.0% | 215,000 | +107.8% | 1.34% | +301.2% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $38,208,000 | -47.8% | 4,776,114 | -49.5% | 1.27% | -9.4% |
| MMSI | Buy | MERIT MED SYS INC | $37,757,000 | +345.8% | 874,013 | +337.0% | 1.25% | +672.8% |
| ARGX | Sell | ARGENX SEsponsored adr | $33,929,000 | +68.0% | 537,361 | -40.3% | 1.12% | +191.5% |
| ALBO | Sell | ALBIREO PHARMA INC | $33,792,000 | -4.6% | 1,320,000 | -21.9% | 1.12% | +65.7% |
| TFX | Buy | TELEFLEX INC | $31,326,000 | +17.3% | 125,900 | +14.0% | 1.04% | +103.5% |
| MYOK | Sell | MYOKARDIA INC | $29,922,000 | -36.6% | 710,726 | -35.5% | 0.99% | +10.1% |
| QTNT | Sell | QUOTIENT TECHNOLOGY INC | $29,683,000 | -19.2% | 6,033,020 | -19.1% | 0.98% | +40.2% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $29,553,000 | -53.9% | 1,987,400 | -39.0% | 0.98% | -19.9% |
| XNCR | Sell | XENCOR INC | $28,783,000 | -51.4% | 1,313,095 | -49.2% | 0.95% | -15.7% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $25,759,000 | -51.1% | 70,585 | +40.1% | 0.85% | -15.1% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $24,710,000 | -34.8% | 2,685,882 | -42.9% | 0.82% | +13.1% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $24,416,000 | -44.2% | 781,309 | -50.0% | 0.81% | -3.2% |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $24,282,000 | -21.3% | 536,626 | -39.3% | 0.80% | +36.7% |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $24,134,000 | – | 200,000 | +100.0% | 0.80% | – |
| DBVT | Sell | DBV TECHNOLOGIES SAsponsored adr | $24,075,000 | -50.8% | 978,619 | -15.1% | 0.80% | -14.6% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $23,954,000 | -38.1% | 427,371 | -42.7% | 0.79% | +7.6% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $23,264,000 | -16.8% | 662,798 | -48.4% | 0.77% | +44.4% |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $21,654,000 | – | 745,135 | +100.0% | 0.72% | – |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $20,981,000 | -52.8% | 3,085,458 | -50.0% | 0.70% | -18.0% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $20,774,000 | -50.7% | 138,626 | -50.0% | 0.69% | -14.4% |
| QURE | Sell | UNIQURE NV | $20,529,000 | +2.8% | 1,047,950 | -49.6% | 0.68% | +78.5% |
| NEPT | Sell | NEPTUNE TECHNOLOGIES BIORESO | $19,762,000 | +140.2% | 8,374,015 | -35.8% | 0.66% | +317.2% |
| AVDL | Sell | AVADEL PHARMACEUTICALS PLCsponsored adr | $19,613,000 | -39.7% | 2,391,841 | -22.8% | 0.65% | +4.7% |
| GLPG | Sell | GALAPAGOS NVspon adr | $19,343,000 | -53.9% | 206,305 | -50.0% | 0.64% | -20.1% |
| HUM | Sell | HUMANA INC | $19,225,000 | -60.5% | 77,500 | -61.2% | 0.64% | -31.5% |
| KDMN | Sell | KADMON HLDGS INC | $18,772,000 | -46.0% | 5,185,847 | -50.0% | 0.62% | -6.2% |
| SRRA | Sell | SIERRA ONCOLOGY INC | $18,650,000 | +64.6% | 5,000,000 | -31.6% | 0.62% | +186.1% |
| NVTA | Sell | INVITAE CORP | $18,200,000 | -48.5% | 2,004,500 | -46.8% | 0.60% | -10.5% |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $17,338,000 | – | 188,893 | +100.0% | 0.58% | – |
| ABEOW | Sell | ABEONA THERAPEUTICS INC*w exp 12/24/201 | $14,612,000 | -53.9% | 1,259,636 | -50.0% | 0.48% | -20.0% |
| RVNC | New | REVANCE THERAPEUTICS INC | $14,300,000 | – | 400,000 | +100.0% | 0.47% | – |
| ADMA | Buy | ADMA BIOLOGICS INC | $12,266,000 | +176.1% | 3,821,102 | +164.9% | 0.41% | +378.8% |
| OMED | Buy | ONCOMED PHARMACEUTICALS INC | $10,745,000 | +14.5% | 2,620,897 | +26.2% | 0.36% | +98.9% |
| TSRO | Sell | TESARO INC | $10,721,000 | -89.3% | 129,372 | -83.4% | 0.36% | -81.5% |
| CLLS | New | CELLECTIS SAsponsored ads | $10,203,000 | – | 350,000 | +100.0% | 0.34% | – |
| CSU | Sell | CAPITAL SR LIVING CORP | $9,176,000 | -34.7% | 680,173 | -39.3% | 0.30% | +13.4% |
| AGRX | New | AGILE THERAPEUTICS INC | $9,092,000 | – | 3,380,000 | +100.0% | 0.30% | – |
| AMGN | New | AMGEN INC | $8,695,000 | – | 50,000 | +100.0% | 0.29% | – |
| Sell | ANI PHARMACEUTICALS INCnote 3.000%12/0 | $8,642,000 | -46.8% | 7,500,000 | -50.0% | 0.29% | -7.7% | |
| AVEO | Sell | AVEO PHARMACEUTICALS INC | $8,253,000 | -67.1% | 2,958,116 | -56.7% | 0.27% | -42.8% |
| FLXN | New | FLEXION THERAPEUTICS INC | $7,712,000 | – | 307,989 | +100.0% | 0.26% | – |
| CDNA | New | CAREDX INC | $7,639,000 | – | 1,040,676 | +100.0% | 0.25% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $7,519,000 | – | 20,000 | +100.0% | 0.25% | – |
| ATRS | Sell | ANTARES PHARMA INC | $7,454,000 | -73.6% | 3,745,662 | -57.0% | 0.25% | -54.2% |
| MRNS | Sell | MARINUS PHARMACEUTICALS INC | $7,407,000 | -56.6% | 907,732 | -68.8% | 0.25% | -24.5% |
| URGN | Sell | UROGEN PHARMA LTD | $7,405,000 | -56.3% | 199,014 | -63.0% | 0.24% | -24.4% |
| MTEM | Sell | MOLECULAR TEMPLATES INC | $7,255,000 | -14.3% | 724,133 | -50.0% | 0.24% | +48.1% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $7,045,000 | -69.2% | 261,134 | -57.3% | 0.23% | -46.5% |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $6,990,000 | -55.3% | 500,356 | -46.2% | 0.23% | -22.4% |
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $6,715,000 | -45.9% | 1,117,324 | -50.0% | 0.22% | -5.9% |
| SYBX | Sell | SYNLOGIC INC | $6,658,000 | -74.5% | 686,352 | -50.0% | 0.22% | -55.6% |
| ABLX | New | ABLYNX NVsponsored adr | $6,248,000 | – | 250,000 | +100.0% | 0.21% | – |
| SELB | Sell | SELECTA BIOSCIENCES INC | $6,206,000 | -85.4% | 632,712 | -72.8% | 0.21% | -74.6% |
| ECYT | New | ENDOCYTE INC | $6,213,000 | – | 1,451,700 | +100.0% | 0.21% | – |
| ZYME | Sell | ZYMEWORKS SHARES | $5,549,000 | -52.4% | 777,497 | -46.8% | 0.18% | -17.5% |
| GMED | New | GLOBUS MED INCcl a | $4,648,000 | – | 113,100 | +100.0% | 0.15% | – |
| CLSD | Sell | CLEARSIDE BIOMEDICAL INC | $4,341,000 | -57.8% | 620,181 | -50.0% | 0.14% | -26.9% |
| ODT | New | ODONATE THERAPEUTICS INC | $3,750,000 | – | 150,000 | +100.0% | 0.12% | – |
| ZLAB | Sell | ZAI LAB LTDadr | $3,715,000 | -60.7% | 175,000 | -50.0% | 0.12% | -31.7% |
| HSGX | Sell | HISTOGENICS CORP | $3,644,000 | -48.2% | 1,777,777 | -50.0% | 0.12% | -9.7% |
| NLNK | Sell | NEWLINK GENETICS CORP | $3,650,000 | -60.2% | 450,000 | -50.0% | 0.12% | -30.9% |
| QTRX | New | QUANTERIX CORP | $3,637,000 | – | 169,400 | +100.0% | 0.12% | – |
| IVC | Sell | INVACARE CORP | $3,370,000 | -57.3% | 200,000 | -50.0% | 0.11% | -25.8% |
| VSAR | Sell | VERSARTIS INC | $3,273,000 | -64.6% | 1,488,160 | -60.6% | 0.11% | -39.0% |
| NEOS | New | NEOS THERAPEUTICS INC | $3,060,000 | – | 300,000 | +100.0% | 0.10% | – |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $2,880,000 | – | 1,000,000 | +100.0% | 0.10% | – |
| BLUE | New | BLUEBIRD BIO INC | $2,565,000 | – | 14,400 | +100.0% | 0.08% | – |
| ALNA | New | ALLENA PHARMACEUTICALS INC | $2,515,000 | – | 250,000 | +100.0% | 0.08% | – |
| VRNA | Sell | VERONA PHARMA PLCsponsored adr | $2,384,000 | -61.2% | 200,000 | -50.0% | 0.08% | -32.5% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $2,324,000 | -40.3% | 102,500 | -50.0% | 0.08% | +4.1% |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $2,199,000 | -36.6% | 157,679 | -50.0% | 0.07% | +10.6% |
| ACER | New | ACER THERAPEUTICS INC | $2,091,000 | – | 150,000 | +100.0% | 0.07% | – |
| VICL | New | VICAL INC | $2,091,000 | – | 1,142,858 | +100.0% | 0.07% | – |
| SBBP | New | STRONGBRIDGE BIOPHARMA PLC | $1,994,000 | – | 275,000 | +100.0% | 0.07% | – |
| BCLI | Sell | BRAINSTORM CELL THERAPEUTICS | $1,568,000 | -52.4% | 400,000 | -50.0% | 0.05% | -17.5% |
| CSBR | Sell | CHAMPIONS ONCOLOGY INC | $1,499,000 | -47.1% | 386,540 | -50.0% | 0.05% | -7.4% |
| CRBP | Sell | CORBUS PHARMACEUTICALS HLDGS | $1,420,000 | -76.0% | 200,000 | -75.9% | 0.05% | -58.4% |
| EXEL | Sell | EXELIXIS SHARES INC | $1,409,000 | -37.3% | 46,361 | -50.0% | 0.05% | +9.3% |
| PFNX | Sell | PFENEX INC | $1,383,000 | -72.9% | 519,773 | -69.3% | 0.05% | -53.1% |
| FCAU | Sell | FIAT CHRYSLER AUTOMOBILES N | $1,106,000 | -50.2% | 62,000 | -50.0% | 0.04% | -11.9% |
| LNTH | Sell | LANTHEUS HLDGS INC | $1,099,000 | -42.6% | 53,763 | -50.0% | 0.04% | -2.7% |
| VCRA | New | VOCERA COMMUNICATIONS INC | $1,063,000 | – | 35,169 | +100.0% | 0.04% | – |
| ABEO | Sell | ABEONA THERAPEUTICS INC | $946,000 | -76.3% | 59,662 | -74.5% | 0.03% | -59.2% |
| AFMD | Sell | AFFIMED NV | $869,000 | -71.1% | 668,214 | -50.0% | 0.03% | -49.1% |
| AZRX | Sell | AZURRX BIOPHARMA INC | $841,000 | -53.6% | 227,272 | -50.0% | 0.03% | -20.0% |
| RXDX | New | IGNYTA INC | $807,000 | – | 30,211 | +100.0% | 0.03% | – |
| ARNA | New | ARENA PHARMACEUTICALS INC | $747,000 | – | 21,978 | +100.0% | 0.02% | – |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $766,000 | -40.3% | 3,448 | -50.0% | 0.02% | 0.0% |
| ALQA | New | ALLIQUA BIOMEDICAL INC | $766,000 | – | 423,394 | +100.0% | 0.02% | – |
| SCMP | New | SUCAMPO PHARMACEUTICALS INCcl a | $719,000 | – | 40,062 | +100.0% | 0.02% | – |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $709,000 | -34.4% | 10,769 | -50.0% | 0.02% | +14.3% |
| CNC | Sell | CENTENE CORP DEL | $676,000 | -54.8% | 6,699 | -56.6% | 0.02% | -24.1% |
| RACE | Sell | FERRARI NV | $650,000 | -52.6% | 6,200 | -50.0% | 0.02% | -15.4% |
| CRIS | Sell | CURIS INC | $666,000 | -76.5% | 951,201 | -50.0% | 0.02% | -59.3% |
| VRX | New | VALEANT PHARMACEUTICALS INTL | $625,000 | – | 30,092 | +100.0% | 0.02% | – |
| PRTO | Sell | PROTEON THERAPEUTICS INC | $635,000 | -52.5% | 334,116 | -50.0% | 0.02% | -19.2% |
| SPPI | New | SPECTRUM PHARMACEUTICALS INC | $609,000 | – | 32,154 | +100.0% | 0.02% | – |
| EVH | Sell | EVOLENT HEALTH INCcl a | $615,000 | -98.0% | 50,000 | -97.1% | 0.02% | -96.5% |
| XBI | New | SPDR S&P BIOTECH ETF SHS PUT 85 01/05/2018put | $579,000 | – | 600,000 | +100.0% | 0.02% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $531,000 | – | 29,091 | +100.0% | 0.02% | – |
| CUTR | Sell | CUTERA INC | $543,000 | -45.2% | 11,981 | -50.0% | 0.02% | -5.3% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $557,000 | -52.8% | 5,700 | -50.0% | 0.02% | -21.7% |
| VRAY | New | VIEWRAY INC | $463,000 | – | 50,000 | +100.0% | 0.02% | – |
| Sell | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $421,000 | -49.9% | 1,000,000 | -50.0% | 0.01% | -12.5% | |
| HCM | Sell | HUTCHISON CHINA MEDITECH LTDsponsored adr | $394,000 | -27.8% | 10,000 | -50.0% | 0.01% | +30.0% |
| KERX | Sell | KERYX BIOPHARMACEUTICALS INC | $388,000 | -67.2% | 83,386 | -50.0% | 0.01% | -43.5% |
| PGNX | New | PROGENICS PHARMACEUTICALS IN | $368,000 | – | 61,850 | +100.0% | 0.01% | – |
| SENS | Buy | SENSEONICS HLDGS INC | $306,000 | -4.4% | 115,000 | +15.0% | 0.01% | +66.7% |
| ZSAN | Sell | ZOSANO PHARMA CORP | $260,000 | -68.4% | 500,000 | -50.0% | 0.01% | -43.8% |
| CASI | New | CASI PHARMACEUTICALS INC | $272,000 | – | 83,682 | +100.0% | 0.01% | – |
| ACST | Sell | ACASTI PHARMA INCcl a new | $176,000 | -67.0% | 186,559 | -50.0% | 0.01% | -40.0% |
| JUNO | New | JUNO THERAPEUTICS INCcall | $93,000 | – | 300,000 | +100.0% | 0.00% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INCcall | $55,000 | – | 100,000 | +100.0% | 0.00% | – |
| CAPR | New | CAPRICOR THERAPEUTICS INC | $6,000 | – | 4,000 | +100.0% | 0.00% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INCcall | $0 | – | -120,000 | -100.0% | -0.00% | – |
| INCY | Exit | INCYTE CORPcall | $0 | – | -200,000 | -100.0% | -0.00% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCput | $0 | – | -840,000 | -100.0% | -0.00% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCcall | $0 | – | -430,000 | -100.0% | -0.01% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INcall | $0 | – | -500,000 | -100.0% | -0.01% | – |
| MOH | Exit | MOLINA HEALTHCARE INCcall | $0 | – | -100,000 | -100.0% | -0.01% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -15,740 | -100.0% | -0.02% | – |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -105,140 | -100.0% | -0.02% | – | |
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -55,102 | -100.0% | -0.02% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -17,186 | -100.0% | -0.02% | – |
| TDOC | Exit | TELADOC INC | $0 | – | -29,282 | -100.0% | -0.02% | – |
| INOV | Exit | INOVALON HLDGS INC | $0 | – | -60,000 | -100.0% | -0.02% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -140,252 | -100.0% | -0.02% | – |
| PRTK | Exit | PARATEK PHARMACEUTICALS INC | $0 | – | -42,372 | -100.0% | -0.02% | – |
| PRAH | Exit | PRA HEALTH SCIENCES INC | $0 | – | -14,854 | -100.0% | -0.02% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -70,212 | -100.0% | -0.02% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -11,238 | -100.0% | -0.02% | – |
| HSKA | Exit | HESKA CORP | $0 | – | -14,600 | -100.0% | -0.02% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -72,464 | -100.0% | -0.02% | – |
| VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -69,208 | -100.0% | -0.03% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES INC | $0 | – | -109,458 | -100.0% | -0.05% | – |
| ZYNE | Exit | ZYNERBA PHARMACEUTICALS INC | $0 | – | -261,400 | -100.0% | -0.05% | – |
| Exit | XENON PHARMACEUTICALS INC | $0 | – | -1,007,706 | -100.0% | -0.06% | – | |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -270,000 | -100.0% | -0.08% | – |
| MGCD | Exit | MGC DIAGNOSTICS CORP | $0 | – | -504,654 | -100.0% | -0.09% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -0.09% | – |
| OCRX | Exit | OCERA THERAPEUTICS INC | $0 | – | -4,077,760 | -100.0% | -0.09% | – |
| VIVE | Exit | VIVEVE MEDICAL INC | $0 | – | -973,976 | -100.0% | -0.10% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Aput | $0 | – | -1,100,000 | -100.0% | -0.11% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -80,000 | -100.0% | -0.12% | – |
| RGEN | Exit | REPLIGEN INC | $0 | – | -174,800 | -100.0% | -0.13% | – |
| NCNA | Exit | NUCANA PLSsponsored adr | $0 | – | -400,000 | -100.0% | -0.14% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -73,526 | -100.0% | -0.14% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -180,000 | -100.0% | -0.20% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -660,000 | -100.0% | -0.20% | – |
| ACRX | Exit | ACELRX PHARMACEUTICALS INC | $0 | – | -2,489,216 | -100.0% | -0.22% | – |
| CMTA | Exit | CLEMENTIA PHARMACEUTICALS IN | $0 | – | -704,500 | -100.0% | -0.24% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -270,888 | -100.0% | -0.24% | – |
| ATHN | Exit | ATHENAHEALTH SHARES | $0 | – | -140,000 | -100.0% | -0.33% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -19,457,672 | -100.0% | -0.34% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -1,858,920 | -100.0% | -0.56% | – |
| ALQA | Exit | ALLIQUA BIOMEDICAL INC | $0 | – | -8,467,902 | -100.0% | -0.59% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -360,000 | -100.0% | -0.61% | – |
| NXTM | Exit | NXSTAGE MEDICAL INC | $0 | – | -2,529,046 | -100.0% | -1.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.